Literature DB >> 11016975

Hindering auxiliary anchors are potent modulators of peptide binding and selection by I-Ak class II molecules.

R R Latek1, S J Petzold, E R Unanue.   

Abstract

Selection of particular antigen-derived peptides by class II MHC molecules determines the population of complexes represented on the antigen-presenting cell surface and available for T cell receptor engagement. This discriminating selection process results from unique interactions between the spectrum of peptides generated during antigen processing and the MHC molecules. Here, we examined the selection of peptides by the class II MHC, I-A(k). Our results indicate that although peptide primary anchors are key in MHC binding, auxiliary anchors are a powerful regulatory component in the selection of peptides by I-A(k). Study of the segments surrounding the dominant hen egg white lysozome(48-61) epitope demonstrates that auxiliary anchors also are involved in determining the binding register of I-A(k) along an extended peptide. In addition, we found that unique combinations of auxiliary anchors can act in concert to modulate the binding of peptides to I-A(k).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016975      PMCID: PMC17222          DOI: 10.1073/pnas.210384197

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.

Authors:  D H Fremont; M Matsumura; E A Stura; P A Peterson; I A Wilson
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak.

Authors:  C A Nelson; R W Roof; D W McCourt; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules.

Authors:  D A Vignali; R G Urban; R M Chicz; J L Strominger
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

4.  HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.

Authors:  A Sette; J Sidney; C Oseroff; M F del Guercio; S Southwood; T Arrhenius; M F Powell; S M Colón; F C Gaeta; H M Grey
Journal:  J Immunol       Date:  1993-09-15       Impact factor: 5.422

5.  Identification of two distinct properties of class II major histocompatibility complex-associated peptides.

Authors:  C A Nelson; S J Petzold; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

6.  The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.

Authors:  W H Boehncke; T Takeshita; C D Pendleton; R A Houghten; S Sadegh-Nasseri; L Racioppi; J A Berzofsky; R N Germain
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

7.  High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

Authors:  J Hammer; C Belunis; D Bolin; J Papadopoulos; R Walsky; J Higelin; W Danho; F Sinigaglia; Z A Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Comparison of peptides bound to spleen and thymus class II.

Authors:  P Marrack; L Ignatowicz; J W Kappler; J Boymel; J H Freed
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

9.  Immune response gene control of determinant selection. I. Intramolecular mapping of the immunogenic sites on insulin recognized by guinea pig T and B cells.

Authors:  M A Barcinski; A S Rosenthal
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

10.  Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.

Authors:  D A Vignali; J L Strominger
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  6 in total

1.  Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition.

Authors:  Anish Suri; James J Walters; Osami Kanagawa; Michael L Gross; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

2.  Distinct recognition by two subsets of T cells of an MHC class II-peptide complex.

Authors:  Zheng Pu; Javier A Carrero; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 3.  Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common?

Authors:  Emil Unanue; Craig Byersdorfer; Javier Carrero; Matteo Levisetti; Scott Lovitch; Zheng Pu; Anish Suri
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: critical role for asparagine deamidation.

Authors:  S N McAdam; B Fleckenstein; I B Rasmussen; D G Schmid; I Sandlie; B Bogen; N J Viner; L M Sollid
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

5.  Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.

Authors:  Monica Moro; Virginia Cecconi; Chiara Martinoli; Eliana Dallegno; Barbara Giabbai; Massimo Degano; Nicholas Glaichenhaus; Maria Pia Protti; Paolo Dellabona; Giulia Casorati
Journal:  BMC Immunol       Date:  2005-12-05       Impact factor: 3.615

Review 6.  The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?

Authors:  Jiji V D Attia; Charlotte E Dessens; Ricky van de Water; Ruben D Houvast; Peter J K Kuppen; Daniëlle Krijgsman
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.